Ali A. Alshamrani

579 total citations
39 papers, 381 citations indexed

About

Ali A. Alshamrani is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Ali A. Alshamrani has authored 39 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Pharmacology. Recurrent topics in Ali A. Alshamrani's work include MicroRNA in disease regulation (3 papers), Epigenetics and DNA Methylation (3 papers) and Tryptophan and brain disorders (3 papers). Ali A. Alshamrani is often cited by papers focused on MicroRNA in disease regulation (3 papers), Epigenetics and DNA Methylation (3 papers) and Tryptophan and brain disorders (3 papers). Ali A. Alshamrani collaborates with scholars based in Saudi Arabia, India and United States. Ali A. Alshamrani's co-authors include Mandi M. Murph, Wei Jia, Mishal Alsehli, Husam Rajab, Kuwar Mausam, Ahmed Nadeem, Nasser B. Alsaleh, Sabry M. Attia, Saleh A. Bakheet and Sheikh F. Ahmad and has published in prestigious journals such as International Journal of Hydrogen Energy, Fuel and Molecules.

In The Last Decade

Ali A. Alshamrani

39 papers receiving 369 citations

Peers

Ali A. Alshamrani

IMMUN

ONCOL

EEE

Senthil Kumar Ganesan India

Tzu‐Yu Lin Taiwan

Jinyu Su China

Jiawei Zheng China

Luyang Cheng China

Min‐Jung Son South Korea

Junjie Lei China

Ruohan Wang China

Yujuan Wei China

Changsheng Wei China

Senthil Kumar Ganesan India

Ali A. Alshamrani

225 ×1.5

61 ×0.8

33 ×1.0

IMMUN

34 ×1.1

ONCOL

17 ×0.7

EEE

Citations per year, relative to Ali A. Alshamrani Ali A. Alshamrani (= 1×) peers Senthil Kumar Ganesan

Countries citing papers authored by Ali A. Alshamrani

Since Specialization

Citations

This map shows the geographic impact of Ali A. Alshamrani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali A. Alshamrani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali A. Alshamrani more than expected).

Fields of papers citing papers by Ali A. Alshamrani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali A. Alshamrani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali A. Alshamrani. The network helps show where Ali A. Alshamrani may publish in the future.

Co-authorship network of co-authors of Ali A. Alshamrani

This figure shows the co-authorship network connecting the top 25 collaborators of Ali A. Alshamrani. A scholar is included among the top collaborators of Ali A. Alshamrani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali A. Alshamrani. Ali A. Alshamrani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ali, Sajid, Ahmad Salawi, Fahad Y. Sabei, et al.. (2025). A stable curcumin/β-cyclodextrin/ascorbic acid ternary inclusion complexes, docking studies, antimicrobial and anticancer assays. Journal of Inclusion Phenomena and Macrocyclic Chemistry. 105(5-6). 363–376. 2 indexed citations

Choi, Jun‐Ki, et al.. (2025). Comparative assessment of conventional and emerging desalination technologies: a holistic review for sustainable water solutions. Desalination. 614. 119140–119140. 6 indexed citations

Attia, Sabry M., Norah A. Albekairi, Ali A. Alshamrani, et al.. (2024). Dapagliflozin suppresses diabetes-induced oxidative DNA damage and hypermethylation in mouse somatic cells. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 896. 503765–503765. 1 indexed citations

Alshamrani, Ali A., et al.. (2024). Genetic and Epigenetic Biomarkers Associated with Early Relapse in Pediatric Acute Lymphoblastic Leukemia: A Focused Bioinformatics Study on DNA-Repair Genes. Biomedicines. 12(8). 1766–1766. 1 indexed citations

Alsaleh, Nasser B., Mohamed E. Assal, Mohammed A. Assiri, et al.. (2024). Synthesis, Characterization, and Toxicity Assessment of Zinc Oxide-Doped Manganese Oxide Nanoparticles in a Macrophage Model. Pharmaceuticals. 17(2). 168–168. 7 indexed citations

Attia, Sabry M., Ali A. Alshamrani, Sheikh F. Ahmad, et al.. (2024). Dulaglutide reduces oxidative DNA damage and hypermethylation in the somatic cells of mice fed a high‐energy diet by restoring redox balance, inflammatory responses, and DNA repair gene expressions. Journal of Biochemical and Molecular Toxicology. 38(7). e23764–e23764. 3 indexed citations

Alshamrani, Ali A., et al.. (2024). miRNA-driven sensitization of breast cancer cells to Doxorubicin treatment following exposure to low dose of Zinc Oxide nanoparticles. Saudi Pharmaceutical Journal. 32(11). 102169–102169. 3 indexed citations

Attia, Sabry M., Ali A. Alshamrani, Sheikh F. Ahmad, et al.. (2024). Dulaglutide rescues the elevated testicular dysfunction in a mouse model of high-fat diet-induced obesity. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 898. 503805–503805. 1 indexed citations

Alshamrani, Ali A., Sheikh F. Ahmad, Ahmed Nadeem, et al.. (2023). Aflatoxin B1 Exacerbates Genomic Instability and Apoptosis in the BTBR Autism Mouse Model via Dysregulating DNA Repair Pathway. Toxics. 11(7). 636–636. 4 indexed citations

10.

Attia, Sabry M., Ahmed Nadeem, Mohammad Azam Ansari, et al.. (2023). The small molecule Erk1/2 signaling pathway inhibitor PD98059 improves DNA repair in an experimental autoimmune encephalomyelitis SJL/J mouse model of multiple sclerosis. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 889. 503650–503650. 1 indexed citations

11.

Alshamrani, Ali A., Norah A. Albekairi, Sheikh F. Ahmad, et al.. (2023). Impacts of the DPP-4 Inhibitor Saxagliptin and SGLT-2 Inhibitor Dapagliflozin on the Gonads of Diabetic Mice. Biomedicines. 11(10). 2674–2674. 5 indexed citations

12.

Alsaleh, Nasser B., et al.. (2023). Adverse Responses following Exposure to Subtoxic Concentrations of Zinc Oxide and Nickle Oxide Nanoparticles in the Raw 264.7 Cells. Toxics. 11(8). 674–674. 6 indexed citations

13.

Assiri, Mohammed A., Abdul‐Hamid Emwas, Mariusz Jaremko, et al.. (2023). Electronic cigarette vapor disrupts key metabolic pathways in human lung epithelial cells. Saudi Pharmaceutical Journal. 32(1). 101897–101897. 5 indexed citations

14.

Ahmad, Sheikh F., Ahmed Nadeem, Mushtaq Ahmad Ansari, et al.. (2023). CXCR3 antagonist NBI-74330 mitigates joint inflammation in Collagen-Induced arthritis model in DBA/1J mice. International Immunopharmacology. 118. 110099–110099. 11 indexed citations

15.

Alwhaibi, Abdulrahman, et al.. (2023). Vincristine-Induced Neuropathy in Patients Diagnosed with Solid and Hematological Malignancies: The Role of Dose Rounding. Journal of Clinical Medicine. 12(17). 5662–5662. 3 indexed citations

16.

Nadeem, Ahmed, Naif O. Al‐Harbi, Sheikh F. Ahmad, et al.. (2023). Bruton’s tyrosine kinase inhibition suppresses neutrophilic inflammation and restores histone deacetylase 2 expression in myeloid and structural cells in a mixed granulocytic mouse model of asthma. International Immunopharmacology. 117. 109920–109920. 5 indexed citations

17.

Alshamrani, Ali A., et al.. (2023). Comprehensive evaluation of six interventions for hospitalized patients with COVID-19: A propensity score matching study. Saudi Pharmaceutical Journal. 31(4). 517–525. 1 indexed citations

18.

Rasool, Muhammad Fawad, Imran Imran, Hamid Saeed, et al.. (2022). Development and Evaluation of a Physiologically Based Pharmacokinetic Model of Labetalol in Healthy and Diseased Populations. Pharmaceutics. 14(11). 2362–2362. 11 indexed citations

19.

Alasmari, Abdullah F., Nemat Ali, Fawaz Alasmari, et al.. (2020). Elucidation of the Molecular Mechanisms Underlying Sorafenib-Induced Hepatotoxicity. Oxidative Medicine and Cellular Longevity. 2020. 1–10. 17 indexed citations

20.

Jia, Wei, et al.. (2018). miR-122-5p Expression and Secretion in Melanoma Cells Is Amplified by the LPAR3 SH3–Binding Domain to Regulate Wnt1. Molecular Cancer Research. 17(1). 299–309. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact